Preferred Intravenous Dextrose Concentration in Pediatric Hypoglycemia
Dextrose 10% (D10) is preferred over dextrose 25% (D25) for intravenous correction of pediatric hypoglycemia. [1][2]
Peripheral Vein Concentration Safety Considerations
Solutions with concentrations greater than 25% dextrose are not recommended for peripheral venous administration due to risks associated with highly concentrated glucose. [1]
Comparative Practical Selection: D10 vs D25
D10 is preferred because pediatric IV bolus therapy is commonly implemented using D10 formulations, including a bolus of 10% dextrose in water (D10) for rapid correction. [2] D25 is generally used only when a higher glucose concentration is required and when D10 is not sufficient or feasible for the required glucose dosing. [1][2]
Key Evidence Supporting D10 Preference
D10 has been described as effective and safe for treatment of hypoglycemia in pediatric patients. [1] A pediatric-facing neonatal/hyperinsulinism management reference describes IV dextrose bolus therapy using D10 at a dose of 200 mg/kg (2 mL/kg of D10%) followed by continuous D10 infusion for ongoing correction. [2]
Treatment Initiation Contexts
Immediate IV dextrose bolus therapy with D10 is recommended for severe symptomatic hypoglycemia when IV glucose administration is required. [2]
Targets and Ongoing Management After Bolus
Following IV dextrose bolus therapy, a continuous IV D10 infusion is recommended to maintain adequate plasma glucose, with target thresholds in the reference generally emphasizing maintenance above 70 mg/dL in treated states. [2]